33 Information on research grants awarded by most major cancer and biomedical research funding organizations was extracted from 2 databases: the International Cancer Research Partnership (ICRP) database and the Health Research Alliance (HRA) database. Established in 2000, the ICRP is a unique alliance of cancer research funding organizations working together to enhance global collaboration and strategic coordination of research[9] . The ICRP aims to improve access to information about cancer research being conducted and enable cancer funding organizations to maximize the impact of their independent efforts for the benefit of researchers and cancer patients worldwide. The ICRP includes organizations from Australia, Canada, France, Japan, the Netherlands, United Kingdom, and US. ICRP member organizations share funding information in a common format (known as the Common Scientific Outline [CSO]) to facilitate the pooling and evaluation of data across organizations[10-12] . The database includes grants from both government and private, nonprofit cancer research funding organizations from within the ICRP member countries, including the US National Institutes of Health. (For a complete list of ICRP members and CSO codes, see www.icrpartnership.org.) Figure 2: Steps in Metastasis Framework by Steeg[6] , Used For Grants osteoclasts osteoblasts fibroblasts hematopoietic progenitors kupffer cells glial cells astrocytes endothelial cells immune cells angiogenesis dormancy dormancy intravasation, arrest and extravasation invasion metastatic colonization Funded Research Grants Analysis Abbreviations: BH3 = pro-apoptotic member of the Bcl-2 protein family; anti-CTLA4 mAb = anti–cytotoxic T-lymphocyte-associated protein 4 monoclonal antibody; EFGR = another term for ErbB, the epidermal growth factor receptor protein family, , HGF/c-Met = hepatocyte growth factor/MET proto-oncogene, receptor tyrosine kinase; PARP = poly-ADP ribose polymerase, VEGF = vascular endothelial growth factor.